Department of Cardiology, Hadassah University Hospital, Jerusalem, Israel.
Division of Clinical Pharmacy, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
J Thromb Thrombolysis. 2019 May;47(4):550-557. doi: 10.1007/s11239-019-01815-y.
Direct oral anticoagulants (DOACs) are commonly administered at a level that is lower than that recommended by dose reduction criteria. This raises concern regarding the adequacy of anticoagulation achieved. To evaluate the relationship between inappropriate dosing and DOAC levels. Medical records of atrial fibrillation patients who underwent DOAC level testing during 2013-2017 were reviewed. The primary outcomes were drug levels under and above the expected steady-state range, and in the lowest and highest quartiles. Of 143 patients who underwent DOAC measurements, only 87 (60.8%) received the appropriate dose. Levels under the expected range and in the lowest quartile were found in 11.9% and 15.0% of patients treated with appropriate dosing compared to 21% and 41.5% of patients treated with inappropriately low dose. DOAC levels were above the expected range and in the highest quartile in 23.8% and 32.5% of patients treated with the appropriate dose compared to 7.1% and 9.4% treated with inappropriately low dose. In multivariate analysis, the administration of an appropriate DOAC dose was associated with a lower rate of DOAC in the lowest level (adjusted odds ratio [95% CI] 0.30 (0.12, 0.76), P = 0.011). On the other hand, appropriate dose was associated with drug levels in the highest quartile (odds ratio [95% CI] 3.77 (0.12, 0.76), P = 0.011). Treatment with inappropriately low DOAC dosing compared to appropriate dose is associated with lower DOAC levels. However, among those treated with appropriate dosing, a higher proportion had high DOAC levels above the expected range.
直接口服抗凝剂(DOAC)通常以低于剂量减少标准推荐的水平给药。这引起了人们对达到的抗凝充分性的担忧。为了评估不适当剂量与 DOAC 水平之间的关系,回顾了 2013-2017 年间接受 DOAC 水平检测的房颤患者的病历。主要结局是低于和高于预期稳态范围以及最低和最高四分位数的药物水平。在接受 DOAC 测量的 143 名患者中,只有 87 名(60.8%)接受了适当的剂量。与接受适当剂量的患者相比,接受适当剂量的患者中有 11.9%和 15.0%的患者的水平低于预期范围和最低四分位数,而接受剂量过低的患者中则有 21%和 41.5%。在接受适当剂量的患者中,有 23.8%和 32.5%的患者的 DOAC 水平高于预期范围和最高四分位数,而接受剂量过低的患者中则有 7.1%和 9.4%。在多变量分析中,给予适当的 DOAC 剂量与 DOAC 处于最低水平的发生率较低相关(调整后的优势比[95%CI]0.30[0.12,0.76],P=0.011)。另一方面,适当的剂量与最高四分位数的药物水平相关(比值比[95%CI]3.77[0.12,0.76],P=0.011)。与适当剂量相比,使用剂量过低的 DOAC 治疗与 DOAC 水平较低相关。然而,在接受适当剂量治疗的患者中,有更高比例的患者的 DOAC 水平高于预期范围的最高四分位数。